Niagen Bioscience, Inc.
NAGE
$3.65
-$0.15-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.40M | 64.64M | 64.14M | 60.32M | 55.46M |
| Total Receivables | 13.07M | 9.74M | 9.11M | 10.26M | 7.95M |
| Inventory | 24.02M | 20.42M | 18.79M | 14.41M | 11.19M |
| Prepaid Expenses | 1.49M | 1.31M | 1.43M | 1.54M | 1.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 152.00K | 693.00K | 152.00K | 152.00K | 152.00K |
| Total Current Assets | 105.12M | 96.81M | 93.62M | 86.68M | 76.22M |
|
|
|||||
| Total Current Assets | 105.12M | 96.81M | 93.62M | 86.68M | 76.22M |
| Net Property, Plant & Equipment | 3.32M | 3.52M | 3.86M | 4.16M | 4.34M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.49M | 5.66M | 246.00K | 284.00K | 322.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 406.00K | 425.00K | 417.00K | 405.00K | 458.00K |
| Total Assets | 114.33M | 106.41M | 98.14M | 91.53M | 81.34M |
|
|
|||||
| Total Accounts Payable | 13.28M | 10.80M | 12.74M | 13.68M | 10.63M |
| Total Accrued Expenses | 7.62M | 7.72M | 8.70M | 7.38M | 9.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.03M | 1.00M | 978.00K | 963.00K | 948.00K |
| Total Finance Division Other Current Liabilities | 894.00K | 399.00K | 292.00K | 303.00K | 207.00K |
| Total Other Current Liabilities | 894.00K | 399.00K | 292.00K | 303.00K | 207.00K |
| Total Current Liabilities | 22.82M | 19.92M | 22.71M | 22.33M | 20.84M |
|
|
|||||
| Total Current Liabilities | 22.82M | 19.92M | 22.71M | 22.33M | 20.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.54M | 1.82M | 2.08M | 2.33M | 2.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.63M | 8.14M | 2.67M | 2.67M | 2.58M |
| Total Liabilities | 32.00M | 29.87M | 27.46M | 27.33M | 25.99M |
|
|
|||||
| Common Stock & APIC | 240.54M | 241.07M | 239.35M | 237.44M | 232.20M |
| Retained Earnings | -158.21M | -164.53M | -168.66M | -173.24M | -176.85M |
| Treasury Stock & Other | -3.00K | -9.00K | -9.00K | -4.00K | -5.00K |
| Total Common Equity | 82.33M | 76.53M | 70.68M | 64.20M | 55.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 82.33M | 76.53M | 70.68M | 64.20M | 55.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 82.33M | 76.53M | 70.68M | 64.20M | 55.35M |
|
|
|||||